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events’ start on Earth: The first case of Ebola outbreak
in West Africa was confirmed. A total number of sus-
pected and confirmed cases in the Ebola Hemorrhagic
Fever (EHF) outbreak had increased to 28,637 cases,
including 15,249 laboratory-confirmed cases and 11,324
deaths in Guinea, Sierra Leone, Liberia, Nigeria, Mali,
Senegal, Spain, and the United States as of November
29, 2015 [1, 2].
Another unexpected epidemic, Middle East Respira-
tory Syndrome (MERS) outbreak surprised the world
hitting the Republic of Korea (ROK) late in May 2015.
This produced 186 confirmed cases including one case
exported to China and 37 deaths [3]. This hospital-based
outbreak has brought a hug impact on the general public
and economy of ROK, which has one of the most
advanced medical and public health systems in the world.
From the unprecedented outbreaks in West Africa
and Korea showed that health could directly apply to
national security and the necessity for immediate action
to establish global capacity to prevent, detect and
rapidly respond to biological threats like Ebola and
MERS. The Global Health Security Agenda (GHSA)
was launched on February 13, 2014 to secure the world
from infectious disease threats and unite nations to make
new, concrete commitments, and to elevate global
health security as a national leaders-level priority [4].
The G7 endorsed the GHSA in June 2014; and Finland
and Indonesia hosted commitment development meet-
ings in May and August. Ministers and senior officials
from 44 countries and leading international organiza-
tions gathered in the White House, Washington DC to
make specific commitments to implement the GHSA
and to work toward a commitment to assist West Africa
with needed global health security capacity within
3 years.
Countries developed 11 Action Packages to support
the GHSA. The Action Packages are designed to outline
measurable steps required to prevent outbreaks, detect
threats in real time, and rapidly respond to infectious
disease threats whether naturally occurring, the result of
laboratory accidents, or an act of bioterrorism. TheCopyright ª 2015 Korea Centers for Disease Control and Prevention.
under the CC BY-NC-ND license (http://creativecommons.org/licensAction Packages include specific targets and indicators
that can be used as a basis to measure how national,
regional, and global capacities are developed and
maintained over the long-term. The United States has
committed to assist at least 30 countries over five years
to achieve the objectives of the GHSA and has placed a
priority for actions on combating antibiotic resistant
bacteria, to improve biosafety and biosecurity on a
global basis, and preventing bioterrorism [5].
Ten countries have agreed to serve on the GHSA
Steering Group, which has been chaired by Finland
starting in 2015 and Indonesia will take the chairman-
ship in 2016, with representation from countries around
the world, including: Canada, Chile, Finland, India,
Indonesia, Italy, Kenya, the Kingdom of Saudi Arabia,
the Republic of Korea, and the United States. The
Steering Group is charged with tracking progress,
identifying challenges, and overseeing implementation
for achieving the objectives of the GHSA in support of
international standards set by the World Health Orga-
nization, the Food and Agriculture Organization of the
United Nations, and the World Organization for Animal
Health. This includes the implementation of interna-
tionally agreed standards for core capacities, such as the
World Health Organization International Health Regu-
lations, the World Organization for Animal Health
Performance of Veterinary Services Pathway, and other
global health security frameworks. To provide
accountability and drive progress toward GHSA goals,
an independent, objective and transparent assessment
process will be needed. Independent evaluation con-
ducted over the five-year course of the GHSA will help
highlight gaps and needed course corrections to ensure
that the GHSA targets are reached.
In the current special issue of the Osong Public
Health and Research Perspectives, articles on GHSA
are included to celebrate the GHSA second high level
meeting in Seoul, hold in Seoul, Korea in September 7
to 9, 2015.
It is true that until the development of vaccine, rapid
detect, respond and control measures of emerging in-
fectious diseases like EHF and MERS should bePublished by Elsevier Korea LLC. This is an open access article
es/by-nc-nd/4.0/).
S2 Editorialconducted on a global basis. GHSA could provide a
bumper with the world until development of vaccine.
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